Dihydrotachysterol: Difference between revisions
Jump to navigation
Jump to search
Created page with "<languages /> <translate> {{Short description|Chemical compound}} {{Drugbox | verifiedrevid = 460787840 | IUPAC_name = (1''S'',3''E'',4''S'')-3-[(2''E'')-2-[(1''R'',3a''S'',7a''R'')-1-[(''E'',2''R'',5''R'')-5,6-Dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1''H''-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol | image = Dihydrotachysterol.svg | alt = Structural formula | image2 = Dihydrotachysterol molecule spacefill.png | alt2 = Space-filling model of the..." |
Marked this version for translation |
||
| Line 1: | Line 1: | ||
<languages /> | <languages /> | ||
<translate> | <translate> | ||
<!--T:1--> | |||
{{Short description|Chemical compound}} | {{Short description|Chemical compound}} | ||
{{Drugbox | {{Drugbox | ||
| Line 44: | Line 45: | ||
}} | }} | ||
<!--T:2--> | |||
'''Dihydrotachysterol''' (DHT) is a synthetic [[vitamin D]] analog activated in the [[liver]] that does not require [[renal]] hydroxylation like vitamin D<sub>2</sub> ([[ergocalciferol]]) and vitamin D<sub>3</sub> ([[cholecalciferol]]). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on [[Mineralization (biology)|mineralization]] of bone salts than does vitamin D. | '''Dihydrotachysterol''' (DHT) is a synthetic [[vitamin D]] analog activated in the [[liver]] that does not require [[renal]] hydroxylation like vitamin D<sub>2</sub> ([[ergocalciferol]]) and vitamin D<sub>3</sub> ([[cholecalciferol]]). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on [[Mineralization (biology)|mineralization]] of bone salts than does vitamin D. | ||
<!--T:3--> | |||
{{Sterols}} | {{Sterols}} | ||
{{Vitamins}} | {{Vitamins}} | ||
{{Vitamin D receptor modulators}} | {{Vitamin D receptor modulators}} | ||
<!--T:4--> | |||
{{二次利用|date=29 January 2023}} | {{二次利用|date=29 January 2023}} | ||
[[Category:Secosteroids]] | [[Category:Secosteroids]] | ||
Latest revision as of 22:28, 12 April 2024
 | |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a682335 |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| Chemical and physical data | |
| Formula | C28H46O |
| Molar mass | 398.675 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Dihydrotachysterol (DHT) is a synthetic vitamin D analog activated in the liver that does not require renal hydroxylation like vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). DHT has a rapid onset of action (2 hours), a shorter half-life, and a greater effect on mineralization of bone salts than does vitamin D.
 | この記事は、クリエイティブ・コモンズ・表示・継承ライセンス3.0のもとで公表されたウィキペディアの項目Dihydrotachysterol(29 January 2023編集記事参照)を素材として二次利用しています。 Item:Q22022  |